Revenue growth of leading 25 domestic drug firms is expected to moderate to 8-10 per cent in the next fiscal year, rating ...
Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country’s largest pharmaceutical ... Sun, led by the cancer ...
Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country’s largest pharmaceutical ... Sun, led by the cancer ...
Import Alert 99-48, Detention without Physical Examination of Foods Due to Chemical Contamination, includes a broad range of synthetic contaminants, including benzene, dioxins, polychlorinated ...
NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US Aarhus, Denmark, 22 March 2024 – NMD Pharma A/S ...
NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US Aarhus, Denmark, 22 March 2024 – NMD Pharma A/S ...
Amneal Pharmaceuticals said the Food and Drug Administration has approved its abbreviated new drug application for ciprofloxacin and dexamethasone otic suspension, a combination used to treat ...
NMD Pharma Receives FDA IND Clearance to initiate a Phase 2b Clinical Trial of NMD670 in Generalized Myasthenia Gravis Patients in the US Aarhus, Denmark, 22 March 2024 – NMD Pharma A/S ...
Prevailing regulations state that only “on-label” claims may be used by manufacturers in pharma advertising. A draft guidance released this week by the Food and Drug Administration, provides an ...
a once-daily pill developed by Madrigal Pharmaceuticals. The FDA decision Thursday is for adults with noncirrhotic non-alcoholic steatohepatitis, or NASH. The approval specifically covers those ...
Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech ...
GAITHERSBURG, Md. - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH), a specialty pharmaceutical company known as Shuttle Pharma, has announced significant progress in its mission to enhance ...